Which has the lower trailing P/E, BMY or MDT?

BMY has the lower trailing P/E: BMY trades at 14.02 and MDT at 22.40. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or MDT?

Over the past five years, MDT grew revenue faster — BMY at a 2.08% CAGR versus MDT at 3.51%.

Does BMY or MDT pay a bigger dividend?

BMY yields 3.94% and MDT yields 3.11% based on trailing dividends and the latest price.

Is BMY or MDT more profitable?

BMY runs the higher net margin — BMY at 18.87% versus MDT at 13.93%.

How have BMY and MDT total returns compared?

Over the past 10 years, BMY delivered 5.01% and MDT delivered 3.48% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Medtronic plc (MDT)

A side-by-side comparison of Bristol-Myers Squibb Company and Medtronic plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$130.00B

$63.64HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

MDT

Medtronic plc

$116.43B

$90.96HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — BMY vs MDT

growth of $100 · dividends reinvested · last 10y

BMY +60.4% (+4.8%/yr)MDT +38.9% (+3.3%/yr)BMY compounded faster over this window

BMY MDT

BMY vs MDT: by the numbers

•BMY is the larger company ($130.00B vs $116.43B market cap).
•BMY trades at the lower trailing earnings multiple (14.02 vs 22.40 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (18.87% vs 13.93% net margin).
•MDT grew revenue faster over the past five years (3.51% vs 2.08% CAGR).
•BMY pays the higher dividend yield (3.94% vs 3.11%).

Metrics side by side

Valuation

Metric	BMY	MDT
P/E ratio	14.02	22.40
Forward P/E	9.18	15.23
P/S ratio	2.64	3.10
P/B ratio	5.82	2.32
EV / EBITDA	9.71	14.83
FCF yield	8.80%	5.27%

Profitability

Metric	BMY	MDT
Gross margin	70.16%	66.69%
Operating margin	28.27%	18.08%
Net margin	18.87%	13.93%
ROE	41.59%	10.41%
ROIC	15.47%	6.44%

Dividends

Metric	BMY	MDT
Dividend yield	3.94%	3.11%
Payout ratio	55.29%	70.20%

Growth (annualized)

Metric	BMY	MDT
Revenue CAGR (5Y)	2.08%	3.51%
EPS CAGR (5Y)	9.38%	6.97%
FCF CAGR (5Y)	-0.95%	0.93%
Total return CAGR (5Y)	4.39%	-3.96%

Frequently asked

Which has the lower trailing P/E, BMY or MDT?: BMY has the lower trailing P/E: BMY trades at 14.02 and MDT at 22.40. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or MDT?: Over the past five years, MDT grew revenue faster — BMY at a 2.08% CAGR versus MDT at 3.51%.
Does BMY or MDT pay a bigger dividend?: BMY yields 3.94% and MDT yields 3.11% based on trailing dividends and the latest price.
Is BMY or MDT more profitable?: BMY runs the higher net margin — BMY at 18.87% versus MDT at 13.93%.
How have BMY and MDT total returns compared?: Over the past 10 years, BMY delivered 5.01% and MDT delivered 3.48% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full MDT analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Medtronic P/E ratio Bristol-Myers Squibb dividend yield Medtronic dividend yield Bristol-Myers Squibb ROE Medtronic ROE Bristol-Myers Squibb operating margin Medtronic operating margin Bristol-Myers Squibb revenue growth Medtronic revenue growth Bristol-Myers Squibb free cash flow Medtronic free cash flow

Bristol-Myers Squibb & Medtronic appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.